Provided by Tiger Trade Technology Pte. Ltd.

Ionis Pharmaceuticals

72.34
-2.4500-3.28%
Post-market: 72.01-0.3300-0.46%19:11 EDT
Volume:2.46M
Turnover:178.74M
Market Cap:11.95B
PE:-30.39
High:74.30
Open:74.30
Low:72.01
Close:74.79
52wk High:86.74
52wk Low:23.95
Shares:165.19M
Float Shares:164.00M
Volume Ratio:0.96
T/O Rate:1.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.3800
EPS(LYR):-2.3812
ROE:-70.80%
ROA:-7.31%
PB:24.43
PE(LYR):-30.38

Loading ...

Dawnzera™ (Donidalorsen) Receives Positive Opinion From Chmp, Recommended for Approval in EU for Hereditary Angioedema (Hae)

THOMSON REUTERS
·
Nov 14, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APA

Reuters
·
Nov 14, 2025

Shares of Ionis Pharmaceuticals Fall 3% After $700 Mln Convertible Bonds Sale

THOMSON REUTERS
·
Nov 13, 2025

BUZZ-Ionis Pharma dips after $700 mln convertible bonds sale

Reuters
·
Nov 13, 2025

BRIEF-Ionis Prices $700 Million Aggregate Principal Amount Of 0.00% Convertible Senior Notes Due 2030

Reuters
·
Nov 13, 2025

Ionis Pharmaceuticals Inc: Pricing of $700.0 Mln Aggregate Principal Amount of 0.00% Convertible Senior Notes Due 2030

THOMSON REUTERS
·
Nov 13, 2025

Ionis Prices Convertible Notes Offering to Refinance 2026 Convertible Notes

THOMSON REUTERS
·
Nov 13, 2025

Ionis Pharmaceuticals to Present at Stifel Healthcare Conference

Reuters
·
Nov 13, 2025

Arrowhead Has Large Market Opportunity With Severe Hypertriglyceridemia Treatment, Morgan Stanley Says

MT Newswires Live
·
Nov 13, 2025

BUZZ-Ionis Pharma up after unveiling $700 mln convertible bonds offering

Reuters
·
Nov 12, 2025

Ionis Pharmaceuticals Shares up 3.2% After the Bell; Announces Proposed Convertible Offering to Refinance 2026 Convertible Notes

THOMSON REUTERS
·
Nov 12, 2025

Ionis Pharmaceuticals announces $700M convertible senior notes offering

TIPRANKS
·
Nov 12, 2025

BRIEF-Ionis Announces Proposed Convertible Offering To Refinance 2026 Convertible Notes

Reuters
·
Nov 12, 2025

Ionis Pharmaceuticals Announces $700 Million Convertible Senior Notes Offering

Reuters
·
Nov 12, 2025

Ionis Pharmaceuticals Inc - Grants Option for Additional $70 Mln Notes

THOMSON REUTERS
·
Nov 12, 2025

Merck's Heart Pill Slashes Cholesterol Levels in Test Patients -- Barrons.com

Dow Jones
·
Nov 11, 2025

Ionis Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Nov 10, 2025

Ionis Pharmaceuticals Reports Olezarsen Cuts Triglycerides and Acute Pancreatitis in sHTG Phase 3 Trial

Reuters
·
Nov 10, 2025

U.S. RESEARCH ROUNDUP-DoorDash, Honeywell, Zscaler

Reuters
·
Nov 10, 2025

Promising Potential of Ionis Pharmaceuticals’ Olezarsen Drives Buy Rating

TIPRANKS
·
Nov 10, 2025